Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Prakash Sampath

Neurological Surgery Providence, RI Medical Doctor

NPI 1689657306 CMS profile 121090

120 Dudley St, Providence, RI 02905

Open in the dashboard

General payments

$36,640

788 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Prakash Sampath of Providence, RI is reported in the CMS Open Payments database as having received $36,640 across 788 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,127 144
2024 General $5,909 72
2023 General $5,347 90
2022 General $6,124 147
2021 General $5,852 124
2020 General $3,337 84
2019 General $3,944 127

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Prakash Sampath
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Prakash Sampath were reported at $6,127. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Prakash Sampath Neurological Surgery median Middle half National median
2019 $3,944 $582 $138–$3,006 $163
2020 $3,337 $294 $76–$2,174 $114
2021 $5,852 $387 $105–$2,432 $132
2022 $6,124 $542 $139–$2,989 $149
2023 $5,347 $534 $145–$2,697 $160
2024 $5,909 $574 $155–$3,046 $164
2025 $6,127 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $15,760 274 payments
  2. Stryker Corporation $14,738 452 payments
  3. Bioventus LLC $2,000 3 payments
  4. VB Spine LLC $992 20 payments
  5. Alphatec Spine, Inc $559 5 payments
  6. Leica Microsystems (Schweiz) AG $550 1 payment
  7. SI-BONE, Inc. $369 5 payments
  8. Cerapedics, Inc. $355 2 payments
  9. NuVasive, Inc. $349 3 payments
  10. Kuros Biosciences USA, Inc $252 4 payments
  11. Other $716 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $27,376 758 payments
  2. Travel and Lodging $3,844 15 payments
  3. Royalty or License $2,896 11 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,875 2 payments
  5. Consulting Fee $550 1 payment
  6. Education $99 1 payment
Products named General payments · program years 2019–2025
  1. VITOSS Bone Substitutes $4,486 146 payments
  2. EXCELSIUS GPS $4,046 69 payments
  3. ExcelsiusGPS Robotic Navigation System Robotics $2,646 27 payments
  4. H-LINK (Royalty Pymt) $2,210 7 payments
  5. BONESCALPEL & SONICONE (O.R.) $1,875 2 payments
  6. CREO $1,411 37 payments
  7. EVEREST SPINAL SYSTEM $1,275 25 payments
  8. VITOSS Bone Substitutes $1,213 84 payments
  9. ExcelsiusGPS Robotic Navigation System Spine/Spine Surgery $1,088 16 payments
  10. AVIATOR $1,018 34 payments
  11. Other $20,757 450 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$143,842

Medicare's payments for the services billed

Medicare patients

74

Average age 74

Services billed

372

38 women, 36 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 43%
Depression 41%
Ischemic heart disease 34%
COPD 27%
Chronic kidney disease 24%
Cancer 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

788 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record